Pharming says Fabrice Chouraqui will step down as CEO effective immediately
The board appointed Leverne Marsh and Kenneth Lynard as interim co-CEOs effective immediately.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pharming announces CEO transition
Leiden, the Netherlands, September 29, 2026: Pharming (Euronext Amsterdam: PHARM/NASDAQ:PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the Board of Directors and Fabrice Chouraqui have mutually agreed that Mr. Chouraqui will step down as Chie…
Pharming announces CEO transition
Pharming announced a CEO transition.